vTv Therapeutics

(NASDAQ) VTVT

Current Price$31.44

Market Cap$124.42M

Since IPO (2015)-93%

5 Year-71%

1 Year+91%

1 Month-2%

vTv Therapeutics Financials at a Glance

Market Cap

$124.42M

Revenue (TTM)

$36.84M

Net Income (TTM)

$2.25M

EPS (TTM)

-$0.92

P/E Ratio

-34.20

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$31.44

Volume

30,977

Open

$30.84

Price

$31.44

Volume

30,977

Open

$30.84

Previous Close

$31.59

Daily Range

$30.51 - $31.92

52-Week Range

$14.00 - $44.00

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$31.44

Volume

30,977

Open

$30.84

Previous Close

$31.59

Daily Range

$30.51 - $31.92

52-Week Range

$14.00 - $44.00

Estimated Earnings Date

Aug 11, 2026

VTVT News

No articles available.

VTVT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About vTv Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Paul Jai Sekhri

Website

www.vtvtherapeutics.com

Headquarters

High Point, NC 27265, US

VTVT Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-8%

Net Income Margin

Return on Equity

Return on Capital

-3%

Return on Assets

Earnings Yield

-2.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$124.42M

Shares Outstanding

3.94M

Volume

30.98K

Avg. Volume

51.54K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$32.81M

EBITDA

-$31.06M

Operating Cash Flow

-$25.26M

Capital Expenditure

$0.00

Free Cash Flow

-$25.26M

Cash & ST Invst.

$88.93M

Total Debt

$0.00

vTv Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$36.84M

N/A

Gross Profit

$36.84M

N/A

Gross Margin

100.00%

N/A

Market Cap

$124.42M

N/A

Market Cap/Employee

$5.41M

N/A

Employees

N/A

Net Income

$24.13M

+574.0%

EBITDA

$23.26M

+458.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$98.09M

+215.8%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

2.28%

N/A

Return on Invested Capital

-3.31%

N/A

Free Cash Flow

$9.15M

+261.0%

Operating Cash Flow

$9.15M

+261.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FBIOFortress Biotech, Inc.

FBIOFortress Biotech, Inc.$2.76-0.36%

GANXGain Therapeutics, Inc.

GANXGain Therapeutics, Inc.$1.69+3.05%

NRXPNRx Pharmaceuticals, Inc.

NRXPNRx Pharmaceuticals, Inc.$3.92+4.26%

SPRBSpruce Biosciences, Inc.

SPRBSpruce Biosciences, Inc.$49.11+4.19%

INKTMiNK Therapeutics, Inc.

INKTMiNK Therapeutics, Inc.$12.34+1.19%

OTLKOutlook Therapeutics, Inc.

OTLKOutlook Therapeutics, Inc.$1.10+23.60%

CRVOCervoMed Inc.

CRVOCervoMed Inc.$2.44+8.44%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$116.96+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.65+0.09%

SPCEVirgin Galactic

SPCEVirgin Galactic$5.73+0.22%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.83-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.01+0.10%

NOKNokia

NOKNokia$14.09+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.04-0.05%

Questions About VTVT

What is the current price of vTv Therapeutics?

vTv Therapeutics is trading at $31.59 per share.

What is the 52-week range for vTv Therapeutics?

Over the past 52 weeks, vTv Therapeutics has traded between $14.00 and $44.00.

How much debt does vTv Therapeutics have?

As of the most recent reporting period, vTv Therapeutics reported total debt of $0.00.

How much cash does vTv Therapeutics have on hand?

vTv Therapeutics reported $98.09M in cash and cash equivalents in its most recent financial results.

What is vTv Therapeutics’s dividend yield?

vTv Therapeutics does not currently have a dividend yield.

vTv Therapeutics

vTv Therapeutics Financials at a Glance

VTVT News

VTVT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About vTv Therapeutics

VTVT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

vTv Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VTVT

What is the current price of vTv Therapeutics?

What is the 52-week range for vTv Therapeutics?

How much debt does vTv Therapeutics have?

How much cash does vTv Therapeutics have on hand?

What is vTv Therapeutics’s dividend yield?

Premium Investing Services